-
Kazuhito Suzuki
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Hideki Uryu
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Tadahiro Gunji
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Kei Hirano
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan, Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University Kashiwa Hospital, Kashiwa, Chiba, Japan
-
Takashi Nakamura
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan, Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University Kashiwa Hospital, Kashiwa, Chiba, Japan
-
Keita Ishii
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan, Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University Kashiwa Hospital, Kashiwa, Chiba, Japan
-
Ryoko Fukushima
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Hiroki Yokoyama
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Hiroto Ishii
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Rika Hosoba
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Daiki Hattori
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Mamiko Momoki
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Yasutaka Mochizuki
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Riku Nagao
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,
-
Mitsuji Katori
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan, Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University Kashiwa Hospital, Kashiwa, Chiba, Japan
-
Kaichi Nishiwaki
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan, Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University Kashiwa Hospital, Kashiwa, Chiba, Japan
-
Shingo Yano
Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan,